Ceres, Inc. 4
4 · Ceres, Inc. · Filed Aug 22, 2013
Insider Transaction Report
Form 4
Ceres, Inc.CERE
Olivier de Vezin Edmund Martin
Director
Transactions
- Gift
Common Stock
2013-08-21−6,666→ 0 total - Gift
Common Stock
2013-08-21+6,666→ 25,896 total(indirect: See Footnote)
Holdings
- 162,406(indirect: See Footnote)
Common Stock
- 581,930(indirect: See Footnote)
Common Stock
- 221,110(indirect: See Footnote)
Common Stock
- 776,515(indirect: See Footnote)
Common Stock
- 103,229(indirect: See Footnote)
Common Stock
Footnotes (7)
- [F1]Transfer of 6,666 shares held directly by the reporting person to the Edmund and Ellen Olivier Revocable Family Trust. The transfer results in a change of ownership from direct to indirect. The transfer reported herein does not change the number of shares benefically owned by the reporting person.
- [F2]By the Edmund and Ellen Olivier Revocable Family Trust.
- [F3]By Oxford Bioscience Partners II LP, who directly holds these securities. The reporting person is one of the general partners of OBP Management II LP, which is the general partner of Oxford Bioscience Partners II LP. The reporting person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, if any.
- [F4]By Oxford Bioscience Partners (Adjunct) II LP, who directly holds these securities. The reporting person is one of the general partners of OBP Management II LP, which is the general partner of Oxford Bioscience Partners (Adjunct) II LP. The reporting person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, if any.
- [F5]By Oxford Bioscience Partners (Bermuda) II Limited Partnership, who directly holds these securities. The reporting person is one of the general partners of OBP Management (Bermuda) II Limited Partnership, which is the general partner of Oxford Bioscience Partners (Bermuda) II Limited Partnership. The reporting person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, if any.
- [F6]By Oxford Bioscience Partners (GS-Adjunct) II LP, who directly holds these securities. The reporting person is one of the general partners of OBP Management II LP, which is the general partner of Oxford Bioscience Partners (GS-Adjunct) II LP. The reporting person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, if any.
- [F7]By Oxford Bioscience Management Partners II, who directly holds these securities. The reporting person is one of the general partners of Oxford Bioscience Management Partners II. The reporting person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, if any.